Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The Endodermin gene is expressed in the early endoderm and the Spemann organizer of Xenopus embryos. It has previously been shown to be a direct target of the early endodermal transcription factor Xsox17 (Clements et al., 2003, Mech Dev 120:337-348). Here we identify two adjacent control elements in the Endodermin promoter; these drive transcription of the gene in late-gastrulaendoderm and contain consensus Sox-binding sites. We have analyzed one element in detail and show that it responds directly to Xsox17 and that the Sox sites are essential for endodermal expression in transgenic embryos. However, flanking regions on both sides are also essential, indicating that Xsox17 acts in concert with several DNA-binding partners.
Fig. 1 (A) Fluorescence reporting from the vegetal pole. (A1) shows
an embryo expressing GFP from mRNA injected bilaterally into
the vegetal pole at the two-cell stage. There is little fluorescence in
the vegetal pole itself, apart from yellow autofluorescence. (A2)
strong vegetal fluorescence after injecting fluorescein-lysine-dextran.
(A3) shows fluorescence from GFP is easily detected in the
vegetal pole of a GFP mRNA-injected oocyte. (B) Primer extension
analysis of transcription initiation from the endogenous Endodermin
gene. The Endodermin promoter is diagrammed, marking
the two TATA boxes at 65 and 285 bp, as well as the position
of exon 1 and the primer used, 74 bp downstream of the ATG
(green arrow). Below is an autoradiograph of the primer extension
products of Endodermin, as well as Xsox17a as a control. On the
left are dideoxy sequencing reactions, using the primer extension
primers. The primer positions on the extension reactions are
marked with white arrows and the predominant product with black
arrows. In the case of Endodermin there is no single long extension
band. The primer used is 50-AGGATGAGGAGGAGGTGCAG
ACT-30.
Fig. 3 Two promoter fragments, E1 and E2, contain putative Soxbinding
sites and can drive gastrula-stage expression in the endoderm.
The position of the two Pst1/Spe1 fragments, E1 and E2, are
shown at the top. Their expression in partial transgenics is shown
below, using GFP fluorescence and in situ hybridization to GFP
mRNA in different embryos. On the right are shown the sequences
of E and E2, indicating Sox-binding sites (yellow boxes, contained
the core sequence ACAAT), Smad sites (green), FAST-1 sites (blue),
and GATA sites (red). The three Sox sites in E2, of which the central
one is a complex of three overlapping sites, are labelled AâC.
Fig. 4 Xsox17 can induce expression
of the E2 reporter construct. The
GFP in the E1 or E2/basal 169 bp
promoter fusions used for transgenesis
was replaced with firefly luciferase,
and 20 pg of these constructs
was injected bilaterally into the animal
pole, with or without 200 pg of
Xsox17b or Xsox17b::EnR mRNA,
or into the vegetal pole, with or
without Xsox17b::EnR. The basal
169/luciferase reporter is also
shown. Whole embryos were harvested
at early gastrula stages (10.5â
11) and groups of five embryos were
assayed in triplicate for firefly luciferase
activity. (A) Both E1 and E2
reporter constructs are induced
vegetally, but the basal promoter
is not. (B) In contrast, only E2 was
induced by Xsox17 in animal caps,
and it was repressed by Xsox17-
b::EnR. (C) Xsox17b::EnR repressed
E2 reporter expression by
80% in both the animal and vegetal
halves. E1 reporter expression
was also down-regulated by 40%
and 50% in the animal or vegetal
halves, respectively.
Fig. 5 A minimal promoter fragment E2:112, derived from E2,
drives early expression in the endoderm of early Xenopus gastrulae.
Deletion of site A from E2 does not affect endoderm expression (1),
nor is this Sox site sufficient for endoderm expression (2). A GATA
site and flanking sequence is also insufficient for endoderm expression
(3). A reporter construct containing sites B and C drives endoderm
expression (4), but a derivative that lacked site B did not (5). A
reporter construct containing sequence upstream of site C, but which
did not include site C itself, was also insufficient for endoderm expression
(6). Endoderm expression was restored by addition of site B
and upstream flanking sequence (7). A shorter version of this construct
(E2:112) can also drive endoderm expression (8). The constructs
are: (1) 2698/2326; (2) 2733/2698; (3) 2519/2326; (4)
2698/2508; (5) 2609/2508; (6) 2636/2550; (7) 2698/
2550; (8) 2698/2586.
Fig. 6 (1) Site B is necessary but not
sufficient for endoderm expression
of E2:112. In each case, the constructs
are shown on the left and
GFP expression by fluorescence or
in situ is shown on the right. (A, B)
Endodermal expression of E2:112.
(CâF) Reporter constructs containing
site B, with either a 2 or 10 bp
flanking sequence on either side,
were not sufficient for endoderm
expression. (G, H) Deletion of site
B from E2:112 abolished reporter
expression in the endoderm. (IâL)
Endodermal expression was not restored
in reporter constructs containing
site B together with
upstream or downstream sequences
(IâL). (2) The reporter construct
E2:112 is vegetally induced, but
only if the B Sox site is present.
Without this site, Xsox17b represses
luciferase expression, but the B
Sox site relieves this. The constructs
are indicated.
Fig. 7 (1) The E2 element is induced
by Xsox17 in oocytes, showing
a direct effect. A circular
plasmid containing E112 fused to
the actin basal promoter and driving
luciferase was injected into the
nuclei of oocytes, with or without
Xsox17a mRNA and incubated for
18 hr. (2) Late expression of Endodermin
promoter constructs in
transgenics. (A) The Endodermin
196 promoter is expressed in
most regions of the stage 32 embryo,
including the pharynx, but
not the rest of the endoderm. (B)
The basal cardiac actin promoter
shows a similar expression pattern
at stage35. (C) The 3487/1
promoter region does not drive
high-level endodermal expression,
beyond that in the pharynx, already
seen with the 196 bp region
at stage 32. (D) The 7 kb/
2632 region, which includes E1,
drives general endodermal expression
at stage 33. (E) A white light
image of this embryo. (F) E2, fused
to the basal 196 bp region, gives
similar endodermal expression. (G)
A white light image of this embryo.
(HâK) Embryos expressing the
3487/2632 region (encompassing
E1) fused to the basal cardiac
actin promoter. (H) Three embryos
at stage 33. (I, J) Ventral fluorescence
and white light images of
stage 42 embryos. (K) The same
embryo from the right-hand side,
with the pancreas indicated (pc).